1. Home
  2. DUOT vs CELU Comparison

DUOT vs CELU Comparison

Compare DUOT & CELU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DUOT
  • CELU
  • Stock Information
  • Founded
  • DUOT 1990
  • CELU 2016
  • Country
  • DUOT United States
  • CELU United States
  • Employees
  • DUOT N/A
  • CELU N/A
  • Industry
  • DUOT Computer Software: Prepackaged Software
  • CELU Biotechnology: Pharmaceutical Preparations
  • Sector
  • DUOT Technology
  • CELU Health Care
  • Exchange
  • DUOT Nasdaq
  • CELU Nasdaq
  • Market Cap
  • DUOT 48.8M
  • CELU 50.4M
  • IPO Year
  • DUOT N/A
  • CELU N/A
  • Fundamental
  • Price
  • DUOT $5.80
  • CELU $2.30
  • Analyst Decision
  • DUOT Strong Buy
  • CELU
  • Analyst Count
  • DUOT 2
  • CELU 0
  • Target Price
  • DUOT $8.75
  • CELU N/A
  • AVG Volume (30 Days)
  • DUOT 131.2K
  • CELU 89.6K
  • Earning Date
  • DUOT 11-19-2024
  • CELU 12-06-2024
  • Dividend Yield
  • DUOT N/A
  • CELU N/A
  • EPS Growth
  • DUOT N/A
  • CELU N/A
  • EPS
  • DUOT N/A
  • CELU N/A
  • Revenue
  • DUOT $7,346,014.00
  • CELU $48,200,000.00
  • Revenue This Year
  • DUOT $16.88
  • CELU N/A
  • Revenue Next Year
  • DUOT $183.85
  • CELU $233.89
  • P/E Ratio
  • DUOT N/A
  • CELU N/A
  • Revenue Growth
  • DUOT N/A
  • CELU 225.94
  • 52 Week Low
  • DUOT $2.03
  • CELU $1.30
  • 52 Week High
  • DUOT $8.53
  • CELU $7.97
  • Technical
  • Relative Strength Index (RSI)
  • DUOT 51.59
  • CELU 52.94
  • Support Level
  • DUOT $4.90
  • CELU $2.04
  • Resistance Level
  • DUOT $5.61
  • CELU $2.39
  • Average True Range (ATR)
  • DUOT 0.85
  • CELU 0.17
  • MACD
  • DUOT -0.16
  • CELU 0.02
  • Stochastic Oscillator
  • DUOT 30.53
  • CELU 70.76

About DUOT Duos Technologies Group Inc.

Duos Technologies Group Inc operating under its brand name duostech, designs, develops, deploys and operates intelligent technology solutions supporting rail, logistics and intermodal businesses that streamline operations, improve safety and reduce costs. The company's main offering, the Railcar Inspection Portal (RIP), provides both freight and transit railroad customers and select government agencies the ability to conduct fully automated railcar inspections of trains while they are moving at full speed. It has also developed the Automated Logistics Information System (ALIS) which automates gatehouse operations where transport trucks enter and exit large logistics and intermodal facilities. Its segments are Rail, Commercial, Governments, Banking and AI.

About CELU Celularity Inc.

Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells, targeting indications across cancer, immunologic, infectious, and degenerative diseases. It manages its operations through an evaluation of three distinct business segments which include Cell Therapy, Degenerative Disease, and bio-banking. The company generates the majority of its revenue from bio-banking segment.

Share on Social Networks: